N.E.W. Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
N
N.E.W. Advisory Services's GILD Position: Q2 2026 in Review
N.E.W. Advisory Services increased its Gilead Sciences (GILD) stake by 6% in Q2 2026, buying an estimated $82.1K and bringing the position to 10,929 shares worth $1.38M. The position accounts for 0.09% of the portfolio, ranked #86.
N.E.W. Advisory Services first reported a position in GILD in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.44M in Q1 2026. 1,573 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- N.E.W. Advisory Services held 10,929 shares of Gilead Sciences worth $1.38M as of Q2 2026.
- N.E.W. Advisory Services bought 623 Gilead Sciences shares in Q2 2026, an estimated $82.1K.
- Gilead Sciences made up 0.09% of N.E.W. Advisory Services's portfolio in Q2 2026, its #86 holding.
- N.E.W. Advisory Services first reported a position in Gilead Sciences in Q2 2021 and has held it in 20 quarters since.
- N.E.W. Advisory Services's Gilead Sciences position peaked at $1.44M in Q1 2026.
- 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.